← Open Payments lookup

ASHRAF ELSHAFEI: Open Payments

NPI 1083816755 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,718 in 61 payments from 10 companies in 2025. Trend: 2023 $1,225 · 2024 $1,308 · 2025 $1,718

Food & beverage: $1,597Education: $122
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$737
Teva Pharmaceuticals USA, Inc.10$264
E.R. Squibb & Sons, L.L.C.8$219
Otsuka America Pharmaceutical, Inc.8$196
Vanda Pharmaceuticals Inc.3$97
Lundbeck LLC3$82
ABBVIE INC.2$50
Corium, LLC1$26
Janssen Pharmaceuticals, Inc1$24
Supernus Pharmaceuticals, Inc.1$23

Products named: CAPLYTA, COBENFY, UZEDY, ABILIFY MAINTENA, FANAPT, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.

Industry payments across NY — which companies pay providers there.